SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.46
+0.29%
Mkt Cap $32.98M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (7 analysts)
$9.33
Range $7.00 – $11.00
Implied Upside
+169.7%
Consensus $9.33 vs current $3.46
NASDAQ·Healthcare·Biotechnology
$3.46
+0.29%
Mkt Cap $32.98M
Buy
7
Hold
0
Sell
0
Price Target (7 analysts)
$9.33
Range $7.00 – $11.00
+169.7%
Consensus $9.33 vs current $3.46